Rochester, MNNCT06668493Now EnrollingIRB Ready

Upper Tract Urothelial Carcinoma Clinical Trial in Rochester, MN

Access cutting-edge upper tract urothelial carcinoma treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by Ferring Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions...

Expert Care in Rochester

Access upper tract urothelial carcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related upper tract urothelial carcinoma treatment provided free

Apply for This Rochester Location

Check if you qualify for this upper tract urothelial carcinoma clinical trial in Rochester, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Upper Tract Urothelial Carcinoma Study in Rochester

The primary purpose of this trial is to evaluate the safety \& tolerability of Nadofaragene Firadenovec in subjects with LG-UTUC. To help with this evaluation, a safety lead-in period will be conducted for the first 6 subjects. Complete response is at 3 or 6 months defined as absence of any UTUC in the renal pelvis.

Sponsor: Ferring Pharmaceuticals

Who Can Participate

Inclusion Criteria

Aged ≥18 years at the time of signing informed consent. 2. Able to give written informed consent. 3. Have biopsy-proven low-grade upper tract urothelial cancer (LG-UTUC) confirmed by a pathology report ≤2 months prior to enrolment. 4. Have ≥1 measurable papillary low-grade tumour (5-15 mm in maximum diameter), evaluated visually above the ureteropelvic junction before enrolment.
Subjects with low-grade tumour larger than 15 mm will be eligible if endoscopic downsizing of the tumour to 5-15 mm in maximum diameter has been performed before enrolment. 5. Willing to be available for at least 18 months after first dosing. 6. Have life expectancy \>2 years, in the opinion of the investigator. 7. Have an Eastern Cooperative Oncology Group (ECOG) status of 2 or less. 8. Females of reproductive potential must have a negative highly sensitive urine or serum pregnancy test upon entry into this trial and be willing to use highly effective contraception during treatmen

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT06668493) has an active research site in Rochester, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Upper Tract Urothelial Carcinoma Treatment Options in Rochester, MN

If you're searching for upper tract urothelial carcinoma treatment options in Rochester, MN, this clinical trial (NCT06668493) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced upper tract urothelial carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all upper tract urothelial carcinoma clinical trials near you to find additional studies recruiting in your area.

More Bladder Cancer Trials in Rochester, MN

See all bladder cancer clinical trials recruiting in Rochester — not just this study.

Browse Bladder Cancer Trials in Rochester

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, MN